Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 46 (96th)

Prescription Drug Patent Licensing Act

referredUnited States· United States Congress· EN

Introduced

15 January 1979

Last action

15 January 1979 · Introduced

Status

Referred to House Committee on the Judiciary.

Sponsors

Rep. Rosenthal, Benjamin S. [D-NY-8], Rep. Blanchard, James [D-MI-18], Rep. Bingham, Jonathan B. [D-NY-22], Rep. Bonior, David E. [D-MI-10], Rep. Brodhead, William [D-MI-17], Rep. Burton, Phillip [D-CA-6], Rep. Corcoran, Tom [R-IL-14], Rescom. Corrada, Baltasar [I-PR-At Large], Rep. Corman, James C. [D-CA-21], Rep. Dornan, Robert K. [R-CA-46], Rep. Edwards, Don [D-CA-10], Rep. Leland, Mickey [D-TX-18], Rep. McCloskey, Paul N., Jr. [R-CA-12], Rep. Moakley, John Joseph [D-MA-9], Rep. Mottl, Ronald M. [D-OH-23], Rep. Price, Melvin [D-IL-21], Rep. Rangel, Charles B. [D-NY-15], Rep. Rodino, Peter W., Jr. [D-NJ-10], Rep. Scheuer, James H. [D-NY-8], Rep. Stark, Fortney Pete [D-CA-13], Rep. Vento, Bruce F. [D-MN-4], Rep. Weaver, James H. [D-OR-4], Rep. Weiss, Ted [D-NY-17], Rep. Zeferetti, Leo C. [D-NY-15], Rep. Long, Clarence D. [D-MD-2], Rep. Anderson, Glenn M. [D-CA-32]

Subjects

Healthcare

Source updated

2 September 2025

Healthcare

Official sourceView documentsShare

Summary

Prescription Drug Patent Licensing Act - Requires that whenever, upon complaint by a qualified applicant for a license under a drug patent, the Federal Trade Commission determines that such license application was not granted and that the price quoted to druggists by the patentee is more than 500 percent of the total cost of production, the Commission shall order the patentee (under penalty of patent cancellation by the Commissioner of Patents) to grant an unrestricted license to any qualified applicant to make, use, and sell such drug. Permits the Commission to delay the issuance of such order for up to five years to provide a fair return on the patentee's invested capital.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 15 January 1979

    Introduced

    Referred to House Committee on the Judiciary.

    Source: IntroReferral

  2. 15 January 1979

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 15 January 1979

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.